Hepatokine leukocyte cell-derived chemotaxin 2 as a biomarker of insulin resistance, liver enzymes, and metabolic dysfunction-associated steatotic liver disease in the general population.

导出 OA

翻译打印收藏纠错

第一作者： Keita,Suzuki

第一单位： Kanazawa University Advanced Preventive Medical Sciences Research Center, Kanazawa, Ishikawa, Japan.

作者： Keita,Suzuki ^[1] ; Hiromasa,Tsujiguchi ^[2] ; Akinori,Hara ^[2] ; Yumie,Takeshita ^[3] ; Hisanori,Goto ^[3] ; Yujiro,Nakano ^[3] ; Reina,Yamamoto ^[3] ; Hiroaki,Takayama ^[3] ; Atsushi,Tajima ^[4] ; Tatsuya,Yamashita ^[5] ; Masao,Honda ^[5] ; Hiroyuki,Nakamura ^[2] ; Toshinari,Takamura ^[3]

作者单位： Kanazawa University Advanced Preventive Medical Sciences Research Center, Kanazawa, Ishikawa, Japan. ^[1] Kanazawa University Advanced Preventive Medical Sciences Research Center, Kanazawa, Ishikawa, Japan.;Department of Public Health, Graduate School of Advanced Preventive Medical Sciences, Kanazawa University, Kanazawa, Ishikawa, Japan.;Department of Hygiene and Public Health, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Ishikawa, Japan. ^[2] Department of Endocrinology and Metabolism, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Ishikawa, Japan. ^[3] Kanazawa University Advanced Preventive Medical Sciences Research Center, Kanazawa, Ishikawa, Japan.;Faculty of Medicine, Department of Bioinformatics and Genomics, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Ishikawa, Japan. ^[4] Department of Gastroenterology, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Ishikawa, Japan. ^[5]

关键词 Insulin resistance LECT2 MASLD